NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Synaptiq

Synaptiq

Private
Cluj-NapocaHealthcare & Life Scienceshttps://synaptiq.io/

Last Round

Late Seed

Jul 6, 2026

Est. Valuation

$5.85M

Total Funding Raised

$1.26M

Company Overview

Synaptiq is a healthcare technology company that develops AI-powered software to automate the contouring of tumors and organs at risk for radiotherapy treatment planning.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Medical Devices, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

radiotherapy planningauto-contouringmedical AIradiation oncologyAI segmentationsoftware as a medical deviceSaMDclinical workflow automationmedical imaging softwareradiology AItumor delineationhealthtech SaaSPACS integrationdeep learning healthcare

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Synaptiq Comps

Public and private peers based on sector, stage, and business model.

Synaptiq comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Synaptiq Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Late SeedJul 6, 2026
AcceleratorApr 23, 2026
GrantDec 20, 2023
SeedApr 4, 2023
GrantAug 29, 2022
Pre Seed
Oct 19, 2021

Key People

Founding team and executive leadership

Roxana Vesa

Co-Founder & Chief Administrative Officer

Founding Team

Dragos Duse

Chief Executive Officer

Executive Team

Synaptiq Investors

Notable investors and investment history

Synaptiq Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Synaptiq Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Synaptiq's valuation, stock price, and market status.

Firmographic Details

HeadquartersCluj-Napoca
Employee Range21
Year Founded2020
Last FundingJul 6, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.